Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
BioWorld38m
Prime’s $3.61B Bristol Myers deal is year’s fourth largest
In the year’s fourth-largest deal, Prime Medicine Inc. will collaborate with Bristol Myers Squibb Co. in a research collaboration and license agreement totaling $3.61 billion. The two companies plan ...
Cobenfy: The First New Schizophrenia Drug in Decades
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
MedPage Today56m
Mavacamten Shows Promise in Heart Failure With Normal to Supranormal EF
Mavacamten had been FDA approved on the basis of the EXPLORER-HCM trial's finding that the drug resulted in better functional ...